Tensor-based morphometry (TBM) performed using T1-weighted images (T1WIs) is a wellestablished method for analyzing local morphological changes occurring in the brain due to normal aging and disease. However, in white matter regions that appear homogeneous on T1WIs, T1W-TBM may be inadequate for detecting changes that affect specific pathways. In these regions, diffusion tensor MRI (DTI) can identify white matter pathways on the basis of their different anisotropy and orientation. In this study, we propose performing TBM using deformation fields constructed using all scalar and directional information provided by the diffusion tensor (DTBM) with the goal of increasing sensitivity in detecting morphological abnormalities of specific white matter pathways. Previously, mostly fractional anisotropy (FA) has been used to drive registration in diffusion MRI-based TBM (FA-TBM). However, FA does not have the directional information that the tensors contain, therefore, the registration based on tensors provides better alignment of brain structures and better localization of volume change. We compare our DTBM method to both T1W-TBM and FA-TBM in investigating differences in brain morphology between patients with complicated hereditary spastic paraplegia of type 11 (SPG11) and a group of healthy controls. Effect size maps of T1W-TBM of SPG11 patients showed diffuse atrophy of white matter. However, DTBM indicated that atrophy was more localized, predominantly affecting several long-range pathways. The results of our study suggest that DTBM could be a powerful tool for detecting morphological changes of specific white matter pathways in normal brain development and aging, as well as in degenerative disorders. 
fields (the Jacobian) are used, the approach is called tensor-based morphometry (TBM; Ashburner et al., 1998; Ashburner & Friston, 2004; Davatzikos et al., 1996) . An important feature of the deformation field is the determinant of the Jacobian (J). J encodes the volume of the deformed unit-cube after registration, therefore it is a measure of local expansion or contraction of volume. In imaging, a voxel can be considered as a unit-cube. A J value of 1 indicates no change in volume, J < 1 indicates local contraction (i.e., tissue loss), and J > 1 indicates local expansion (i.e., growth), therefore, J can be used as a method to detect local volume change in development or disease. Indeed, TBM has been used to study normal brain development and many brain disorders including Alzheimer's disease, HIV/AIDS, Huntington's disease, and schizophrenia (Chiang et al., 2007; Hua et al., 2008; Kipps et al., 2005; Thompson et al., 2000) . TBM has been predominantly performed using structural MRI images, in particular T1-weighted images (T1WIs) to drive the registration algorithm, as they provide good delineation between white matter, gray matter, and cerebrospinal fluid (CSF). However, it is important to consider that the signal intensity within white matter appears relatively homogenous in T1WIs making it difficult to detect morphological changes of specific white matter pathways contained in large white matter regions.
Diffusion tensor imaging (DTI; Basser, Mattiello, & LeBihan, 1994) is an MRI modality that is particularly suitable for identifying individual white matter pathways (Pierpaoli, Jezzard, Basser, Barnett, & Di Chiro, 1996) . DTI provides information about the principal direction of diffusion which is locally collinear with the orientation of major fiber bundles, as well as scalar metrics, such as fractional anisotropy (FA) and the mean diffusivity (MD; i.e., Trace of the diffusion tensor/3; . TBM has been applied to diffusion MRI data in limited cases. However, mainly the scalar maps derived from DTI, such as FA or low b-value DWIs were used to drive the registration (Oishi et al., 2011; Pagani, Horsfield, Rocca, & Filippi, 2007; Verma et al., 2005) with the exception of work by Studholme (2008) , where a weighted combination of diffusion tensor elements and T1WIs were used. Using the directional information provided by the diffusion tensor enables a better identification of individual white matter pathways compared to using scalar diffusion metrics, such as FA or T1WIs and T2-weighted images (T2WIs; Pajevic & Pierpaoli, 1999) . For example, the cingulum bundle (CB) can easily be differentiated from the corpus callosum (CC) or the corticospinal tract (CST) from the transverse pontine fibers in the directionally encoded color (DEC) maps (Pajevic & Pierpaoli, 1999) , while the demarcation between these pathways is not easy to assess with FA, T1WIs, or T2WIs.
Alignment of diffusion tensor images is a more involved process compared to the alignment of scalar images as the tensors must be reoriented to be consistent with the reorientation of anatomical structures. There has been extensive work on performing proper alignment of diffusion tensor images, for example, using the deviatoric of the diffusion tensor and optimizing tensor orientation explicitly (Zhang et al., 2007) , and using the full diffusion tensor (Irfanoglu et al., 2016) . However, previous work has concentrated on the improvement of registration and subsequent voxelwise analysis of diffusion derived metrics and not on the TBM of deformation fields themselves. In this study, we propose to use diffusion tensor data to drive the registration, taking advantage of both DTI scalar and vectorial information and perform TBM on these deformation fields. We hypothesize that TBM based on deformation fields obtained by registration of diffusion tensors (DTBM) will be more sensitive than TBM based on scalar images, such as T1WIs (T1W-TBM) and FA (FA-TBM) in detecting morphometric changes in specific white matter pathways. We used all the three TBM methods, DTBM, T1W-TBM, and FA-TBM, to assess their ability to characterize morphometric abnormalities with respect to controls in a group of patients with spastic paraplegia of type 11 (SPG11), a rare disorder that is well defined genetically, and has certain disease characteristics involving atrophy of white matter, making it particularly suitable for testing our hypothesis.
Spastic paraplegia of type 11 is a subtype of hereditary spastic paraplegia (HSP), a group of inherited disorders characterized by progressive spasticity and lower limb weakness produced by abnormalities in the protein spatacsin caused by a mutation in the SPG11 gene.
Although the function of spatacsin is not completely clear, current evidence suggests it may be involved in anterograde vesicle trafficking and axonal transport (Pérez-Brangulí et al., 2014) , both of which are expected to play a crucial role in axonal maintenance, in particular for long-range white matter pathways. SPG11 is therefore an appropriate candidate for assessing the sensitivity of TBM methods as multiple white matter pathways including commissural, association, and projection pathways are affected (Cao et al., 2013; Chen et al., 2008; França et al., 2012; Garaci et al., 2014) . A common MRI finding is a thin CC, which is visually detectable (Cao et al., 2013; Fink, 2013; Stevanin et al., 2007) . In addition, a common documented pathological feature of HSP is the axonal degeneration of the CST (motor pathway) along the medulla and spinal cord (Deluca, Ebers, & Esiri, 2004; McDermott, White, Bushby, & Shaw, 2000; Salinas, Proukakis, Crosby, & Warner, 2008; Wharton et al., 2003; White et al., 2000) . We hypothesized that DTBM will have an advantage in detecting CST atrophy, especially at the level of the brainstem where DTI provides additional information (these regions appear homogenous in the T1WIs). Another region of interest is the centrum semiovale where multiple long-range pathways are located, DTBM might be able to detect whether these white matter tracts are differentially affected as this region also appears homogenous in the T1WIs. Moreover, if the role recently proposed for spatacsin by Pérez-Brangulí et al. (2014) in SPG11 involves more selective loss of long-range fibers, DTBM should be able to detect a pattern of white matter atrophy that affects preferentially selected white matter pathways.
| MATERIALS AND METHODS

| Subjects
Twenty-four healthy volunteers (mean age of 35 and standard deviation of six years; 15 female and 9 male) with no history of neurological disorders and normal MRI, and four subjects diagnosed with SPG11 (mean age of 32 and standard deviation of three years; four female) were included in this study. The study was approved by the Ethics Committee and written informed consent was obtained from all subjects.
| Image acquisition
All participants were scanned on a Philips 3T system with a 32-channel head coil. The DTI data were acquired with a single-shot spin-echo 
| Diffusion-weighted image processing
Diffusion-weighted volumes were processed with the diffprep module of the TORTOISE software package 1 Pierpaoli et al., 2010) . 
| Spatial normalization and construction of Jacobian maps
In general, an average template is a 3D image that should represent the average of features (e.g., size, shape, and composition) of the imaged anatomical organ in the population of interest. Spatial normalization is necessary for both constructing the average template and assessing morphological differences between individual subjects and the template. We used two software programs for spatial normalization. For T1W images and FA maps, we used the well-established ANTS software (Avants et al., 2010 (Avants et al., , 2011 . For DTI spatial normalization we used the recently developed DR-TAMAS software (Irfanoglu et al., 2016) .
DR-TAMAS is a diffeomorphic diffusion tensor-based registration
method that uses all scalar and vectorial tensor features (anisotropy, Trace, eigenvectors) in its cost function, achieving good overall quality of registration in white matter, gray matter, and CSF regions (Irfanoglu et al., 2016) . For the purpose of template building, at each iteration, we added the constraint that the sum of the displacement fields from the template to each individual image is zero at each voxel location to ensure the computed template represents the average morphology of the population . We built modalityspecific control templates using ANTS and DR-TAMAS software with the symmetric normalization (SyN) diffeomorphic transformation model option proposed by Avants, Epstein, Grossman, and Gee (2008) . SyN transformation model has been shown to be powerful and fast (Klein et al., 2009; Murphy et al., 2011) .
For each modality (T1W, FA, and DTI), individual subjects were registered to the control template, and the corresponding transformations (combined affine and nonlinear transformations) were used to compute the modality-specific log of determinant of Jacobian (LogJ) maps for each subject. To test the hypothesis that long-range fibers were more selectively affected, deterministic tractography (Mori & van Zijl, 2002; Wang, Benner, Sorensen, & Wedeen, 2007) performed on the DTI average template of the control subjects was used to assess which pathways pass through regions that showed localized atrophy (negative values in the LogJ maps) in SPG11 patients. The angular threshold for terminating streamline propagation was set to 20 as this has been shown to yield relatively higher specificity in the anatomical accuracy of pathways visualized using diffusion tractography (Thomas et al., 2014) . The extracted tracts were identified and labeled according to the terminology used by Catani and de Schotten (2012) .
| Statistical analysis
Permutation testing was performed to determine whether the LogJ maps of SPG11 were significantly different from the control. FSL randomize software was used to determine the p values (Winkler, Ridgway, Webster, Smith, & Nichols, 2014) and corrected for multiple comparisons using family-wise error rate of 5% (p < .05). In addition, effect size maps were computed using the following formula: ([mean of patients] -[mean of controls])/pooled standard deviation. As the two groups are dissimilar in size, we used pooling of weighted standard deviation such that each group's standard deviation is weighted by its sample size (Hedges, 1981) .
3 | RESULTS (Figure 1 ). These white matter tracts include commissural pathways, association pathways (most prominently the AF, but also the IFOF, UF, and CB), and projection pathways (CST). In addition to white matter regions, significant atrophy was also detected in gray matter regions, such as the thalamus (Figure 2e ). The spatial extent of the atrophy detected by T1W-TBM is relatively large but less localized to specific white matter bundles. FA-TBM shows the least spatial extent of atrophy. Interestingly, only DTBM detects significant atrophy of the CST.
In addition to group analysis, we looked at the brain morphology at the single subject level by generating z-score maps for each of the SPG11 subjects (see Supporting Information Figures). DTBM showed a pattern of atrophy that is symmetric between left and right hemispheres and consistent across subjects (Supporting Information Figure S1 ). For example, Supporting Information Figure S1f ,g shows different fiber tracts in centrum semiovale, which are consistently detected for each subject, and the magnitude of the z-scores is larger compared to T1W-TBM and FA-TBM. Atrophy of CST was detected with a z-score of >4 in three of the four SPG subjects (Supporting Information Figure S1a,b) , but was not detected by T1W-TBM and only detected in two subject with a lower z-score by FA-TBM. Similar to the group comparison, T1W-TBM showed diffuse white matter Figure S2 ). FA-TBM showed less atrophy overall compared to the other two methods (Supporting Information Figure S3 ).
| DISCUSSION
In this study, we proposed a novel way of performing TBM that is driven by scalar and vectorial information of the diffusion tensor.
DTBM offers multiple advantages over the scalar-based TBM methods of T1W-TBM and FA-TBM, including the ability to localize patterns of volume change to specific fiber pathways within white matter regions that appear homogenous in T1W images. Additionally, DTBM was found to detect volume changes with higher sensitivity, as indicated by the greater magnitude of its effect size. Finally, DTBM was able to reveal volume abnormalities that were invisible using other TBM methods in tracts with known involvement in HSP, such as the CST (Deluca et al., 2004; McDermott et al., 2000; Salinas et al., 2008; Wharton et al., 2003; White et al., 2000) .
We chose to evaluate brains of SPG11 patients to evaluate the utility of our proposed method, because SPG11 shows evident white matter atrophy in the CC, which could imply atrophy of other longrange white matter pathways (França et al., 2012) , in addition to diffusion anisotropy abnormalities detected using DTI (França et al., 2012; Garaci et al., 2014) . While both morphometric and microstructural alterations are implicated in this disorder, it is important to emphasize that they can have different etiology and consequences, and therefore the primary goal of this study was to evaluate morphometric analysis tools to complement the analysis of DTI scalar quantities, such as FA, that have already been described in the literature.
Given the disorder's rarity, most previous studies including our study are limited to a small number of patients, but anatomical abnormalities that accompany the disorder are quite consistent across subjects and large in magnitude. For example, in several long-range white matter pathways we found an effect size for DTBM that was While voxelwise analysis of FA or MD offers insights about changes in microstructure and architecture (e.g., intravoxel orientational arrangement of fibers) within a structure of interest, DTBM analysis offers insights about changes in the size of a given structure. In some disorders, both the microstructure and the size of the fiber bundle might be affected, which is likely the case for SPG11. Previous studies have indeed found diffuse FA abnormalities in SPG11 (França et al., 2012) .
However, this is not always the case, as FA and volume metrics are intrinsically different. For example, we have recently shown that in Down syndrome using TBSS analysis on FA reveals no differences between patients and controls, while DTBM detects highly significant differences in several brain regions . In another study of patients with Moebius syndrome, we found no significant differences in FA and TR between patients and controls, but DTBM detected atrophy in the posterior pons, including medial longitudinal fasciculus . For SPG11 subjects, in contrast to previous DTI studies where diffuse white matter abnormalities were detected, DTBM was able to localize patterns of volume reduction within the white matter regions and to indicate a more severe and focal atrophy specifically affecting several long-range pathways, including association, commissural, and projection pathways. Given that impaired axonal transport has been implicated in the pathogenesis of SPG11, this finding is consistent with the idea that long-range pathways could be selectively affected in SPG11, because they are more vulnerable to impaired axonal transport.
One can also imagine other scenarios, where DTI measurements and morphometric measurements are affected differently. For example, consider a scenario in which the patient group is characterized by thinning of white matter pathways with preserved microstructure (i.e., fewer fibers, but with the remaining fibers structurally unaltered).
In such a scenario, voxelwise analysis of FA should reveal no decrease in FA (although in practice we may find a reduction in FA, due to the contribution of partial volume contamination from the surrounding tissue). In this case, DTBM analysis would reveal the loss of volume due to a decrease in the number of fibers and provide a better understanding of the underlying change in the white matter structures. In another scenario, it may be that the structure of a fasciculus is altered 
| Image processing factors and their influence on DTBM
One factor that could affect the result of analysis of LogJ maps is the choice of smoothing parameters during registration. DR-TAMAS and ANTS use two sets of smoothing, one is the smoothing of the images and the other is the smoothing of the deformation fields. We use a similar strategy to smooth deformation fields, and we used the same value for the smoothing parameter across all methods when registering all subjects to the control template. In our experience, deformation field smoothing affects the LogJ maps the most and we used zero smoothing to preserve the location of atrophy and avoid blurring of tissue boundaries. Another parameter that could also affect the results is the step size used in the registration optimization algorithm. We also ensured that these parameters are consistent between the two programs. A small amount of smoothing can lead to a negative Jacobian, which is inconsistent with diffeomorphism. However, excessive smoothing can also blur the tissue boundaries. In this study, we decided to use limited image smoothing and no smoothing for deformation fields to preserve tissue boundaries and avoid blurring in the LogJ maps, however, this resulted in a negative Jacobian for a few voxels in the CC for SPG11 patients. In the future, development of the anisotropic smoothing kernel used during registration might remedy some of these issues.
It is worth noting that LogJ maps are also affected by the arrangement and sparsity of the fibers in the white matter bundle. For example, as is evident in Figure 1 , a reduction in the CST volume is apparent in the LogJ maps of DTBM at the level of the medulla, but is not evident at the level of the pons. While taking this finding at face value may lead to the unlikely conclusion that the CST is differently impacted at different levels of the brainstem, a more plausible explanation is that the voxels containing the CST at the level of the medulla contain only CST fibers, whereas at the level of the pons they contain the CST as well as other pathways. In general, in regions containing multiple white matter pathways, the magnitude of the selective shrinkage of one of them will be diluted. For example, if pathway A represents 10% of the tissue in the voxel and its volume is reduced by 50%, the overall volume reduction in that voxel would be 5%, whereas if the pathway is the only white matter bundle in the voxel then the measured volume reduction would be 50%. Using multi-fascicle registration methods such as the one proposed by Taquet et al. (2014) should improve DTBM in the crossing fiber regions.
Another important issue that could potentially affect the DTBM analysis is geometric distortion of the DTI data. We used registration of B0 images to undistorted T2W images to correct for distortion (Wu et al., 2008) . However, one could use field maps or, if the data were acquired with multiple phase encoding directions, an algorithm such as DR-BUDDI (Irfanoglu et al., 2015) can be used to correct for this distortion.
| CONCLUSIONS
All TBM methods appear to detect white matter abnormalities, however, our findings suggest that DTBM is more informative and enables a better localization of white matter change within regions that appear homogenous in T1W images. Relative to FA-TBM, DTBM shows more severe white matter atrophy and is able to detect enlargement of CSF spaces and atrophy of gray matter regions. As DR-TAMAS takes the full diffusion tensor into account and uses deviatroic and Trace metrics when registering subjects to the control template, DTBM is able to detect differences even in regions with low anisotropy. DTBM 
